Less hepatic decompensation events but rising liver cancer in hepatitis B patients on long-term nucleos(t)ide therapy

AIDS Rev. 2022;24(4):197. doi: 10.24875/AIDSRev.M22000055.
No abstract available

MeSH terms

  • Antiviral Agents / therapeutic use
  • DNA, Viral
  • HIV Infections* / drug therapy
  • Hepatitis B virus / genetics
  • Hepatitis B* / complications
  • Hepatitis B* / drug therapy
  • Humans
  • Liver Neoplasms* / etiology
  • Nucleosides
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Nucleosides
  • DNA, Viral